NST-SPARK Open-Label Phase 1 STTR (IGNITE)
NST-SPARK Open-Label Phase 1 STTR (IGNITE)
Not yet recruiting · NCT07593456 · Registry updated 2026-05-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| NST-SPARK Open-Label Phase 1 STTR (IGNITE) | Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophrenia | Not yet recruiting | Not applicable | 2026-05-18 | NCT07593456 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| North Shore Therapeutics, Inc. | 1 |
| Northwell Health | 107 |
| University of Pennsylvania | 502 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Perelman School of Medicine | Philadelphia | United States | 3 |
| Zucker Hillside Hospital | Glen Oaks | United States | 4 |